Current State and Utility of Biomarkers in Acute Respiratory Distress Syndrome

May 17, 2018 (Noon - 1:30 p.m. ET)


Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act (BPCA), NICHD


6700A Rockledge Drive, Bethesda, MD


Anil Sapru, M.D. and Michael A. Matthay, M.D., will review biomarker studies for acute respiratory distress syndrome in children and adults. They will also the discuss the possible use of biological markers to improve the design of clinical trials.

Dr. Sapru is a professor of pediatrics and the division chief of critical care at the UCLA Mattel Children's Hospital. Dr. Matthay is a professor of medicine and anesthesia at the University of California at San Francisco. He also is a senior associate at the Cardiovascular Research Institute.


George Giacoia, OPPTB, NICHD
Phone: (301) 496-5589

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of pageBACK TO TOP